Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-01 Sale | 2026-10-05 5:43 pm | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 8,400 | $78.5 | $659,387 | 23,453 (Indirect Direct) | View |
| 2026-09-24 Sale | 2026-09-28 8:47 pm | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 29,056 | $88 | $2,556,851 | 204,330 (Indirect Direct) | View |
| 2026-08-26 Sale(A) | 2026-08-28 8:18 pm | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 4,090 | $111.39 | $455,567 | 25,791 (Indirect Direct) | View |
| 2026-08-25 Sale(A) | 2026-08-28 7:41 pm | Monopar Therapeutics | MNPR | Anderson Raymond Director | 3,142 | $111.98 | $351,835 | 11,656 (Direct) | View |
| 2026-08-26 Sale | 2026-08-27 7:29 pm | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 1 | $111.26 | $111 | 5,065 (Direct) | View |
| 2026-08-26 Sale | 2026-08-27 6:28 pm | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 4,090 | $111.39 | $455,567 | 7,396 (Direct) | View |
| 2026-08-25 Sale | 2026-08-27 6:27 pm | Monopar Therapeutics | MNPR | Anderson Raymond Director | 3,142 | $111.77 | $351,189 | 23,751 (Direct) | View |
| 2025-12-26 Purchase | 2025-12-29 12:15 pm | Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer | 1,500 | $69.95 | $104,925 | 1,500 (Direct) | View |
| 2025-12-18 Sale | 2025-12-19 3:43 pm | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 5,121 | $67.15 | $343,889 | 8,762 (Direct) | View |
| 2025-09-24 Sale | 2025-09-26 3:53 pm | Monopar Therapeutics | MNPR | Tactic Pharma LLC Robinson Chandler Brown Michael J O'Halloran Thomas V. Mazar Andrew Paul 10% Owner | 550,229 | $63.61 | $34,999,957 | 272,026 (Direct) | View |
| 2025-07-14 Sale | 2025-07-16 9:06 pm | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 8,904 | $40 | $356,171 | 11,486 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-20 Tax Withholding | 2026-10-20 4:59 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 597 | $92.59 | 166,942 (Direct) | View |
| 2026-10-01 Exercise | 2026-10-05 5:43 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 8,400 | $0.005 | 23,453 (Direct) | View |
| 2026-10-01 Exercise | 2026-10-05 5:43 pm | N/A 2027-02-19 | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 8,400 | $0 | 23,453 (Direct) | View |
| 2026-09-30 Exercise | 2026-10-02 6:15 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,384 | $0 | 93,169 (Direct) | View |
| 2026-09-30 Tax Withholding | 2026-10-02 6:15 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,944 | $79.67 | 93,169 (Direct) | View |
| 2026-09-30 Exercise | 2026-10-02 6:14 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 9,801 | $0 | 251,141 (Direct) | View |
| 2026-09-30 Tax Withholding | 2026-10-02 6:14 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,344 | $79.67 | 251,141 (Direct) | View |
| 2026-09-30 Exercise | 2026-10-02 6:14 pm | N/A N/A | Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer | 614 | $0 | 10,639 (Direct) | View |
| 2026-09-30 Tax Withholding | 2026-10-02 6:14 pm | N/A N/A | Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer | 180 | $79.67 | 10,639 (Direct) | View |
| 2026-09-24 Exercise | 2026-09-28 8:47 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 15,000 | $14 | 204,330 (Direct) | View |
| 2026-09-24 Exercise | 2026-09-28 8:47 pm | N/A 2028-08-08 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 29,056 | $0 | 204,330 (Direct) | View |
| 2026-09-24 Exercise | 2026-09-28 8:47 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 14,056 | $30 | 204,330 (Direct) | View |
| 2026-08-26 Exercise(A) | 2026-08-28 8:18 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 2,035 | $14 | 25,791 (Direct) | View |
| 2026-08-26 Exercise(A) | 2026-08-28 8:18 pm | N/A 2028-08-27 | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 4,090 | $0 | 25,791 (Direct) | View |
| 2026-08-26 Exercise(A) | 2026-08-28 8:18 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 2,055 | $30 | 25,791 (Direct) | View |
| 2026-08-25 Exercise(A) | 2026-08-28 7:41 pm | N/A 2027-09-17 | Monopar Therapeutics | MNPR | Anderson Raymond Director | 3,142 | $0 | 11,656 (Direct) | View |
| 2026-08-25 Exercise(A) | 2026-08-28 7:41 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 3,142 | $30 | 11,656 (Direct) | View |
| 2026-08-26 Exercise | 2026-08-27 7:29 pm | N/A N/A | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 1,380 | $0.005 | 5,065 (Direct) | View |
| 2026-08-26 Exercise | 2026-08-27 7:29 pm | N/A 2026-12-14 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 1,380 | $0 | 5,065 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 7:38 pm | N/A N/A | Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer | 1,228 | $0 | 10,819 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 7:38 pm | N/A N/A | Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer | 507 | $92.59 | 10,819 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 7:38 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 12,873 | $0 | 255,485 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 7:38 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,084 | $92.59 | 255,485 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 5,254 | $0 | 95,113 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 2,309 | $92.59 | 95,113 (Direct) | View |
| 2026-06-26 Option Award | 2026-06-30 4:57 pm | N/A 2036-06-26 | Monopar Therapeutics | MNPR | Sweeny Nicole Director | 1,284 | $0 | 1,284 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-02 3:03 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 6,732 | $0 | 259,569 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-02 3:03 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 1,972 | $54.79 | 259,569 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-02 3:03 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 3,514 | $0 | 97,422 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-02 3:03 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,571 | $54.79 | 97,422 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 5:25 pm | N/A 2036-03-02 | Monopar Therapeutics | MNPR | Rodriguez Susan CCSO | 48,728 | $0 | 48,728 (Direct) | View |
| 2025-01-28 Other | 2026-01-30 2:31 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 62,815 | $0 | 211,348 (Indirect) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 3:46 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 2,558 | $65.3 | 470,752 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 3:46 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 8,724 | $0 | 470,752 (Direct) | View |
| 2025-12-31 Tax Withholding | 2026-01-05 3:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,889 | $65.3 | 98,993 (Direct) | View |
| 2025-12-31 Exercise | 2026-01-05 3:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,326 | $0 | 98,993 (Direct) | View |
| 2026-01-01 Option Award | 2026-01-05 3:45 pm | N/A 2036-01-01 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 2,000 | $0 | 2,000 (Direct) | View |
| 2025-12-16 Other | 2025-12-17 3:42 pm | N/A N/A | Monopar Therapeutics | MNPR | Hendricks Diane 10% Owner | 43,499 | $0 | 704,829 (Indirect) | View |
| 2025-12-16 Other | 2025-12-17 3:41 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 7,710 | $0 | 21,593 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:50 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 22,888 | $0 | 61,562 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:50 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:49 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:48 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:48 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Talukdar Lavina Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:47 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:47 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer | 16,961 | $0 | 16,961 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:46 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 65,886 | $0 | 138,485 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-02 3:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,896 | $81.67 | 86,963 (Direct) | View |
| 2025-09-30 Exercise | 2025-10-02 3:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,327 | $0 | 86,963 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-02 3:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 2,646 | $81.67 | 424,177 (Direct) | View |
| 2025-09-30 Exercise | 2025-10-02 3:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 8,726 | $0 | 424,177 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 9:06 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 8,904 | $0.005 | 11,486 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 9:06 pm | N/A 2026-04-04 | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 8,904 | $0 | 11,486 (Direct) | View |